Modified Hood Technique 機器手臂攝護腺切除術於器官侷限性攝護腺癌中促進早期尿控恢復並維持良好短期腫瘤結果
劉順琳1、曾浩翔1,2、蔡禮賢1、林維卿3、張菡4、張兆祥1
1中國醫藥大學附設醫院泌尿部,3醫學影像部,4病理部; 2中國醫藥大學北港附設醫院泌尿部
Modified Hood Technique with Urethropexy in Robotic Radical Prostatectomy Facilitates Early Continence Recovery with Acceptable Short-Term Oncological Outcomes in Organ-Confined Prostate Cancer
Shun-Lin Liu1, Hao Xiang Chen1,2, Li-Hsien Tsai1, Wei-Ching Lin3, Han Chang4, Chao-Hsiang Chang1
1Department of Urology, 3Medical Imaging, 4Pathology, China Medical University Hospital, China Medical University, Taichung 404, Taiwan; 2 Division of Urology, Department of Surgery, China Medical University Beigang Hospital, Beigang, Yunlin, 651012, Taiwan.
Purpose: To evaluate the functional and oncological outcomes of modified hood technique robotic radical prostatectomy in patients with clinically organ-confined prostate cancer.
Materials and Methods: We retrospectively reviewed patients with prostate cancer staged as MRI T<=2, who underwent robotic radical prostatectomy using the modified hood technique at a single center by a single surgeon. Preoperative, pathological, functional, and oncological outcomes were analyzed.
Results: From November 2021 to June 2025, a total of 104 patients were included. The median age was 67 years and median PSA level was 7.39 ng/mL. Continence rates at 1 week, 3 months, and 12 months were 37.5%, 79.8%, and 94.2%, respectively.
Pathological upstaging occurred in 27.8% of patients, and the positive surgical margin rate was 29.8%. During a median follow-up of 25 months, 14.2% of patients received adjuvant or salvage treatment, and only 1 patient had a PSA level >0.2 ng/mL at the most recent follow-up.
Conclusions: Modified hood technique robotic radical prostatectomy may facilitate early continence recovery while maintaining acceptable short-term oncological outcomes in patients with clinically organ-confined prostate cancer.